Screening active compounds acting on the epidermal growth factor receptor from Radix scutellariae via cell membrane chromatography online coupled with HPLC/MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 62, Issue , 2012, Pages 196-202

  He, Huaizhen ^a   Han, Shengli ^a   Zhang, Tao ^a   Zhang, Jie ^a   Wang, Sicen ^a   Hou, Jingjing ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cell membrane chromatography; Epidermal growth factor receptor; High performance liquid chromatography mass spectrometry; Radix scutellariae; Wogonin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; PLANT EXTRACT; RADIX SCUTELLARIAE EXTRACT; UNCLASSIFIED DRUG; WOGONIN;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL VIABILITY; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIX SCUTELLARIAE; TANDEM MASS SPECTROMETRY;

CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MASS SPECTROMETRY; PLANT EXTRACTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REFERENCE STANDARDS; SCUTELLARIA BAICALENSIS;

EID: 84862806699     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.12.025     Document Type: Article

References (21)

1. Xu S., Wang L., Yang Q.F., Meng Q.G. Antiviral effect and mechanism of Scutellaria baicalensis Georgi. Chin. Arch. Tradit. Chin. Med. 2007, 25:1355-1357.
2. Mei L., He X.Z., Xiong Y., Shi K.Y., Lin Y., Hu C.B. Study of antibacterial activities test in serum of Scutellaria baicalensis Georgi. J. Med. Res. 2009, 38:102-103.
3. Zhou Z.X., Fu Y.Y. Effect of baicalin on enzyme activity of Candida albicans. Lishizhen Med. Mater. Med. Res. 2007, 18:2639-2640.
4. Xu S., Meng Q.G. Advance of Research on Antipyretic effect and mechanism of Scutellaria. Chin. Arch. Tradit. Chin. Med. 2008, 26:1179-1181.
5. Tang R.Y., Zhou W.Z. Studies on the hypotensive effect of huang-chin. Acta Physiol. Sin. 1958, 22:91-97.
6. Ke H., Pan L.R., Wang Y. Comparative study on anti-inflammatory effects of Scutellaria baicalensis from different habit mod. J. Integr. Tradit. Chin. Western Med. 2009, 18:2902-2903.
7. Sugawa N., Ekstrand A.J., James C.D., Collins V.P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:8602-8606.
8. Ogiso H., Ishitani R., Nureki O., Fukai S., Yamanaka M., Kim J.H., Saito K., Sakamoto A., Inoue M., Shirouzu M., Yokoyama S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002, 110:775-787.
9. Richard J., Sainsbury C., Needham G.K., Farndon J.R., Malcolm A.J., Harris A.L. Epidermal-growth-factor receptor status as predict of early recurrence of and death from breast cancer. Lancet 1987, 329:1398-1402.
10. Radinsky R., Risin S., Fan D., Dong Z.Y., Bielenberg D., Bucana C.D., Fidler I. Level and function of epidermal growth factor receptor predicts the metastatic potential of human colon carcinoma cells. J. Clin. Cancer Res. 1995, 1:19-31.
11. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., Louis D.N., Christiani D.C., Settleman J., Haber D.A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004, 350:2129-2139.
12. Wakeling A.E., Guy S.P., Woodburn J.R., Ashton S.E., Curry B.J., Barker A.J., Gibson K.H. An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res. 2002, 62:5749-5754.
13. Zhang Y.M., Li X., Xu X.M., Luo W.J. Construction of a high-EGFR expression cell line and its biological properties comparing with A431 cell. Afr. J. Biotechnol. 2010, 30:4674-4680.
14. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70:461-477.
15. Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000, 287:1964-1969.
16. He L.C., Geng X.D. Determination of ligustilide in rat blood and tissues by capillary gas chromatography/mass spectrometry. New Prog. Biomed. Chromatogr. 1996, 3:8-9.
17. Wang L., Ren J., Sun M., Wang S.C. A combined cell membrane chromatography and online HPLC/MS method for screening compounds from Radix caulophylli acting on the human α1A-adrenoceptor. J. Pharm. Biomed. Anal. 2010, 51:1032-1036.
18. Sun M., Ren J., Du H., Zhang Y.M., Zhang J., Wang S.C., He L.C. A combined A431 cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening compounds from total alkaloid of Radix caulophylli acting on the human EGFR. J. Chromatogr. B 2010, 878:2712-2718.
19. Xiong S.H., Xiong A.Z., Fang X., Jiang Y., Luo X.H. Extraction process of Radix scutellariae with orthogonal test design. Chin. Med. Hera 2008, 5:46-47.
20. Zhu Y., Wang X.H. Extraction process of Radix scutellariae with orthogonal test. Anhui Med. Pharm. J. 2006, 10:250-251.
21. Naruse I., Ohmori T., Ao Y., Fukumoto H., Kuroki T., Mori M., Saijo N., Nishio K. Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo. Int. J. Cancer 2002, 98:310-315.